Access
Email Verification
Agenda 2024
TBC
0830 - 0930 REGISTRATION AND MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1005 UNDERSTANDING THE REALITY OF THE MICROBIOME: HOW REAL IS REAL
- The limitations of current methods in accurate analysis of the microbiome
- Importance of precise microbial population assessment in disease-related studies
- Critical analysis of ‘16S rRNA amplicon sequencing’ for microbial quantification
- Suitability of ‘fluorescence in situ hybridization’ to improve the accuracy of assessment
Jiri Snaidr
vermicon AG
vermicon AG
1005 - 1010 Q&A SESSION ON WHY AND HOW TO ASSESS THE EXACT STATE OF MICROBIOME
1010 - 1030 SPEED NETWORKING SESSION
- Exchange business cards and get connected in short one-to-one meetings
- Start the conversation to arrange a more formal meeting later on in the conference
- Share your professional background and discuss your biggest business issues – Don't forget your business cards!
Conference Host
1030 - 1100 MORNING COFFEE BREAK IN THE EXHIBIT AREA
1100 - 1125 SOLVING MICROBIOME STRUCTURE – FUNCTION PROBLEMS
- The mapping of microbiome composition to its functional impact on health and ecology
- Microbiome-based predictions of ecological function across different environments
- Redefining microbiome feature descriptions through advanced experimental techniques
Otto Cordero
Massachusetts Institute of Technology
Massachusetts Institute of Technology
1125 - 1130 Q&A SESSION ON EXPLORING MICROBIOME FUNCTIONALITY AND COMPOSITION
1130 - 1155 GUT HEALTH AND ITS IMPACT ON BRAIN HEALTH
- Exploring the human microbiome as a pivotal source for new therapeutics and diagnostics
- The connection between the gut and brain via the autonomic nervous system and HPA axis
- Understanding how gut health influences mood, cognition, and overall mental health
Leigh Richardson
The Brain Performance Center
The Brain Performance Center
1155 - 1200 Q&A SESSION ON THERAPEUTIC INSIGHT IN GUT-BRAIN INTERACTION
1200 - 1330 NETWORKING LUNCH & VISIT THE FUTURE MICROBIOME EXHIBITION
1330 - 1355 METATRANSCRIPTOMICS IN ORAL MICROBIOME: DECIPHERING HUMAN HEALTH LINKS
- Exploring the role of RNA in human-microbiome interactions for chronic disease management
- Role of Meta transcriptomics data from saliva for microbial functional pathways quantification
- Impact of periodontal disease, acid reflux, and nicotine addiction on oral pathway scores
Lan Hu
Viome Life Sciences, Inc.
Viome Life Sciences, Inc.
1355 - 1400 Q&A SESSION ON ASSOCIATION OF RNA DATA FROM ORAL MICROBIOME AND HUMAN HEALTH
1400 - 1425 EXPLORING NOVEL MICROBIAL THERAPIES FOR HEPATOCELLULAR CARCINOMA
- Investigating new microbe-based treatments to combat hepatocellular carcinoma
- Uncovering the role of microbial therapies in cancer treatment advancements
- Impact of microbial metabolites on fatty liver disease and cancer therapy
Louis Cohen
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
1425 - 1430 Q&A SESSION ON TREATING LIVER CANCER WITH MICROBES AND MICROBIAL METABOLITES
1430 - 1500 AFTERNOON COFFEE BREAK IN THE EXHIBIT AREA
1500 - 1530 RESERVED PRESENTATION
1530 - 1600 RESERVED PRESENTATION
1600 - 1625 CONTAMINATION AND BIAS: TOWARDS ROBUST ANALYSIS OF LOW-BIOMASS MICROBIOMES
- Methodologies for pinpointing and eliminating microbiome contamination
- Introducing bias correction techniques to enhance microbiome study accuracy
- Improving cancer phenotype predictions through refined microbiome analysis
Tal Korem
Columbia University
Columbia University
1625 - 1630 Q&A SESSION ON IMPROVING MICROBIOME STUDY ACCURACY AND PREDICTION
1630 - 1730 NETWORKING DRINKS RECEPTION
TBC
0900 - 0930 MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1005 MICROBIOME PRODUCT FORMULATION THROUGH LEVERAGING BIG DATA AND AI
- The shift from expert-guessed formulations to data-driven microbiome products
- Using big data for precise formulation based on diverse individual microbiome profiles
- Real-world case studies to understand the impact of data-driven formulation processes
Afif Ghannoum
BIOHM Health LLC
BIOHM Health LLC
1005 - 1010 Q&A SESSION ON REVOLUTIONIZING MICROBIOME FORMULATION WITH DATA AND AI
1010 - 1035 THE FUTURE OF SKIN MICROBIOME TESTING: INSIGHTS AND ADVANCEMENTS
- Probiotic encapsulation in anti-microbial sanitizers and its effects
- Discussion on microbial signatures and dermo types in Atopic Dermatitis
- Analyzing age-related changes in skin microbiome across diverse populations
- Developing intimate area microbiome products and their Community State Types
Emma Gray
Sequential
Sequential
1035 - 1040 Q&A SESSION ON RECENT PROGRESS ON SKIN MICROBIOME TESTING
1040 - 1100 MORNING COFFEE BREAK IN THE EXHIBIT AREA
1100 - 1125 AN AI-ENABLED METABOLOMICS-BASED PIPELINE FOR MICROBIOME-DERIVED SMALL MOLECULE MULTI-FUNCTIONAL THERAPEUTICS
- Integrating culturomics and metabolomics with AI to discover and develop microbial natural products for inflammatory diseases
- Current efforts in targeting conditions such as eczema and pre-cancerous actinic keratosis through our innovations
- Exploring opportunities for partnership in the creation of natural product-based consumer goods with corporations
Hannah Wastyk
Interface Biosciences
Interface Biosciences
1125 - 1130 Q&A SESSION ON MICROBIOME SMALL MOLECULE THERAPEUTICS DEVELOPMENT THROUGH AI
1130 - 1155 ENGINEERED PROBIOTICS FOR THERAPEUTIC DELIVERY
- Limosilactobacillus reuteri as a delivery vehicle for biotherapeutics
- Leveraging bacteriophage lysis for precise therapeutic release
- Advancing in vivo therapeutic delivery through preclinical models
In Young Choi
University of Wisconsin
University of Wisconsin
1155 - 1200 Q&A SESSION ON ENGINEERED PROBIOTICS AS A THERAPEUTIC VEHICLE
1200 - 1225 HUMAN MILK VARIATION IMPACTS THE INFANT GUT MICROBIOME
- Exploration of maternal genetics, milk composition and infant gut microbiome by multi-omics
- New findings on milk gene expression and its effect on Bifidobacteria levels in the infant gut
- Discussing the role of human milk oligosaccharides in infant development and gut microbiome health
Ran Blekhman
The University of Chicago
The University of Chicago
1225 - 1230 Q&A SESSION ON MILK VARIATION AND INFANT GUT MICROBIOME IMPACTS
1230 - 1245 FEEDBACK & RAFFLE DRAW
1245 - 1400 NETWORKING LUNCH
Quick Proposal
Key topics for 2024 :
- The human microbiome as a source of therapeutics and diagnostics
Understanding the microbiota “signature” and how to use it as a biomarker to predict and treat human diseases. - New techniques to identify interactions between microbiota and diseases
Look for the latest developments of how various microbiota communicates with the host and the factors that influence these interactions. - Key technologies for the discovery of microbiome-based medicines
Explore how the latest mapping and profiling technologies can be used to manipulate the microbiome for preventing and curing diseases through the development of new therapies. - Latest research and developments in skin, gut, and oral microbiome
Defining the skin microbiome and understanding the role of the microbiome in women’s and infant health, gut, and beyond the gut. - How to overcome barriers in the adoption of microbiome-based therapies
Learn the key regulatory and commercial considerations for approval and acceptance of microbiome-based therapeutics to treat diseases. - Advances in microbiome commercialization and the latest therapeutic trends
Marketing new probiotics for therapeutic purposes and the latest trends in using beneficial microbes to develop the next generation of drugs..
Sponsorship Opportunities
Join us as a sponsor for this IQ International conference! Reach your target audience, limit competitor influence at the conference and become a keynote speaker, while sharing your company's solutions for this industry.
- Get registration discounts
- Enhance your brand awareness
- Additional marketing opportunities